SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE L impact

Cinclus Pharma says all Phase III patients completed treatment

Cinclus Pharma reported that all patients have completed treatment in its Phase III study, per a Redeye analyst research note.

CINPHA

Redeye’s analyst published a Research Note on Cinclus Pharma.Click here to read the articleMake sure to add Cinclus Pharma to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies.About Redeye Nordic Growth ABThis is a press release from Red…